Gerresheimer Sells Centor and Plastics Units to Apax for $1.71 Billion
German pharmaceutical packaging company Gerresheimer has agreed to sell its U.S.-based Centor business and global primary plastics unit to private equity firm Apax Funds in a deal valued at approximately €1.5 billion ($1.71 billion), including debt. The transaction is expected to strengthen Gerresheimer's financial position by allowing it to focus on core pharmaceutical packaging operations while offloading non-core assets. The Centor business specializes in glass vials and syringes, whereas the plastics unit produces primary packaging for injectable drugs. Both units are being sold as part of a strategic shift aimed at streamlining Gerresheimer's portfolio and improving operational efficiency.
